Liquid Biopsy in Alzheimer’s Disease Patients Reveals Epigenetic Changes in the PRLHR Gene
Cells · 2023
DOI: 10.3390/cells12232679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Mónica Macías und 10 weiteren Autor:innen. Beteiligte Einrichtung: Navarrabiomed, Hospital Universitario de Navarra, Universidad Pública de Navarra, IdiSNA, 31008 Pamplona, Spain. Hauptthemen laut MEDLINE: Alzheimer Disease, Cell-Free Nucleic Acids, Epigenesis, Genetic, Liquid Biopsy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gobierno de Navarra, Instituto de Salud Carlos III, LaCaixa Foundation.
Themen: Demenz
Abstract (Originalsprache)
In recent years, new DNA methylation variants have been reported in genes biologically relevant to Alzheimer’s disease (AD) in human brain tissue. However, this AD-specific epigenetic information remains brain-locked and unreachable during patients’ lifetimes. In a previous methylome performed in the hippocampus of 26 AD patients and 12 controls, we found higher methylation levels in AD patients in the promoter region of PRLHR, a gene involved in energy balance regulation. Our aim was to further characterize PRLHR’s role in AD and to evaluate if the liquid biopsy technique would provide life access to this brain information in a non-invasive way. First, we extended the methylation mapping of PRLHR and validated previous methylome results via bisulfite cloning sequencing. Next, we observed a positive correlation between PRLHR methylation levels and AD-related neuropathological changes and a decreased expression of PRLHR in AD hippocampus. Then, we managed to replicate the hippocampal methylation differences in plasma cfDNA from an additional cohort of 35 AD patients and 35 controls. The isolation of cfDNA from the plasma of AD patients may constitute a source of potential epigenetic biomarkers to aid AD clinical management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Navarrabiomed, Hospital Universitario de Navarra, Universidad Pública de Navarra, IdiSNA, 31008 Pamplona, Spain.
- Neurology Department, Hospital Universitario de Navarra, IdiSNA, 31008 Pamplona, Spain.
ORCID-Profile: Mónica Macías, Amaya Urdánoz-Casado, Miren Roldan, Ivonne Jericó, Idoia Blanco-Luquin, Maite Mendioroz
Förderung
- Gobierno de Navarra
- Instituto de Salud Carlos III
- LaCaixa Foundation
- Fundación Luzón
- La Caixa Foundation
- Government of Navarra
- Spanish Government
- European Regional Development Fund (ERDF), European Union
Zitieren
APA
Macías, M., Acha, B., Corroza, J., Urdánoz-Casado, A., Roldan, M., Robles, M., Sánchez-Ruiz de Gordoa, J., Erro, M. E., Jericó, I., Blanco-Luquin, I., & Mendioroz, M. (2023). Liquid Biopsy in Alzheimer’s Disease Patients Reveals Epigenetic Changes in the PRLHR Gene. Cells. https://doi.org/10.3390/cells12232679
Vancouver
Macías M, Acha B, Corroza J, Urdánoz-Casado A, Roldan M, Robles M, et al. Liquid Biopsy in Alzheimer’s Disease Patients Reveals Epigenetic Changes in the PRLHR Gene. Cells. 2023. doi:10.3390/cells12232679
BibTeX
@article{Macas2023,
author = {Macías, Mónica and Acha, Blanca and Corroza, Jon and Urdánoz-Casado, Amaya and Roldan, Miren and Robles, Maitane and Sánchez-Ruiz de Gordoa, Javier and Erro, María Elena and Jericó, Ivonne and Blanco-Luquin, Idoia and Mendioroz, Maite},
title = {Liquid Biopsy in Alzheimer’s Disease Patients Reveals Epigenetic Changes in the PRLHR Gene},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12232679}
}
EUVIMED